The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma

MLA

Jones, K., et al. The Impact of HLA Class I and EBV Latency-II Antigen-Specific CD8+ T Cells on the Pathogenesis of EBV+ Hodgkin Lymphoma. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315697307&authtype=sso&custid=ns315887.

APA

Jones, K., Wockner, L., Brennan, R., Keane, C., Chattopadhyay, P., Roederer, M., Price, D., Cole, D., Hassan, B., Beck, K., Gottlieb, D., Ritchie, D., Seymour, J., Vari, F., Crooks, P., Burrows, S., & Gandhi, M. (2016). The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma.

Chicago

Jones, K, L Wockner, Rm Brennan, C Keane, Pk Chattopadhyay, M Roederer, Da Price, et al. 2016. “The Impact of HLA Class I and EBV Latency-II Antigen-Specific CD8+ T Cells on the Pathogenesis of EBV+ Hodgkin Lymphoma.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315697307&authtype=sso&custid=ns315887.